Showing 36,902 results

Filters
Pharmaceutical industry

Pfizer sells its stake in GSK's ViiV for $1.9B, with Shionogi upping its ante in the HIV-focused company

Editor's pick
FiercePharma
26 January 2026
Mpox

Post-Mpox Side Effects Persisted More Than a Year After Acute Infection

Editor's pick
MedPage Today
26 January 2026
Sexually transmitted infections prevention

ECDC issues guidance on doxycycline for STI prevention

Editor's pick
European Centre for Disease Prevention and Control (ECDC)
26 January 2026
The search for an HIV prevention vaccine

The near death - and last-minute reprieve - of a trial for an HIV vaccine

Editor's pick
NPR
26 January 2026
Treatment outcomes & life expectancy

ART Scale-Up Reduces Orphanhood in HIV-Affected Children

Editor's pick
European Medical Journal
26 January 2026
Neurological & cognitive problems

Delayed treatment of HIV linked to greater risk of dementia

Editor's pick
Kaiser Permanente
26 January 2026
Government, leadership & policy

One Year Later

Editor's pick
AVAC
15 January 2026
Global health initiatives

One year after US aid freeze, HIV care in Africa is in retreat

Editor's pick
Devex (requires free registration)
27 January 2026
Bad science & bogus treatments

Peter H. Duesberg, 89, Renowned Biologist Turned H.I.V. Denialist, Dies

Editor's pick
The New York Times (requires free registration)
28 January 2026
Confidentiality, consent & medical ethics

Does HIV cure-related research cause anxiety for participants?

Editor's pick
i-Base
28 January 2026
Improving HIV care

People With HIV Are Eager for More Trauma Screening Than Guidelines Recommend, Study Suggests

Editor's pick
TheBodyPro
28 January 2026
Health services & systems

Florida Moves to Cut AIDS Drug Assistance Program — and Drops the Most Prescribed HIV Regimen in the Country

Editor's pick
HIV and ID Observations
28 January 2026
Global health initiatives

Trump Administration’s Inhumane Global Gag Rule Expansion and New Gender and Equity Foreign Aid Restrictions Will Cost Lives

Editor's pick
Health GAP (Global Access Project)
28 January 2026
PrEP policies & guidelines

Malta: Government rolls out free HIV prevention medicines PEP and PrEP

Editor's pick
Malta Today
30 January 2026
Global health initiatives

The sorry fate of primary prevention in America's global HIV plans

Editor's pick
To End a Plague ... Again
30 January 2026
Global health initiatives

Latest US Restrictions on Aid ‘Bully’ Recipients to Accept ‘Extremist Ideology’

Editor's pick
Health Policy Watch
30 January 2026
HIV treatment

Withdrawal of cobicistat (Tybost) from the UK by end of 2026

Editor's pick
i-Base
30 January 2026
PrEP policies & guidelines

US: ‘Transformative’ HIV PrEP shot slowly overcomes cost hurdles

Editor's pick
The Hill
1 February 2026
Access to healthcare

Florida Judge to Hear Challenge That Would Stop Cuts to AIDS Drug Assistance Program

Editor's pick
POZ
6 February 2026
PrEP policies & guidelines

Where is HIV prevention drug lenacapavir in ‘America First’ health deals?

Editor's pick
Devex (requires free registration)
6 February 2026
Human rights

Uganda's anti-gay law exposes systemic failures

Editor's pick
Deutsche Welle
6 February 2026
Bad science & bogus treatments

No, Gammora is not a ‘cure’ for HIV. False promises and fake medicine being sold on social media

Editor's pick
Africa Check
6 February 2026
Global health initiatives

Global Fund Launches Process to Select New Executive Director

Editor's pick
Global Fund
6 February 2026
Mental & emotional health problems

Landmark HIV study shows scalable model for integrating depression care into HIV services in Uganda

Editor's pick
London School of Hygiene and Tropical Medicine
6 February 2026